Eligo Bioscience

Healthcare & Life Sciences

Recent Finacing

Non-dilutive financing

Recent Raise

$5M

Eligo Bioscience is a gene-editing biotech company focused on developing precision medicines for immuno-inflammation, oncology, and infectious diseases by leveraging microbiome in-vivo gene editing technologies.